In recent years, many biomarkers, such as IDH1/IDH2, MGMT, TP53, TERT, and 1p/19q, have prognostic significance22, 23; however, the existing molecules could not completely explain all the malignant biological behaviors of low‐grade gliomas.7, 24. This evidence concerns the gene IDH2 and central nervous system cancer.